The N-methyl-D-aspartate receptor subunits NR2A and NR2B bind to the SH2 domains of phospholipase C-gamma.
The NMDA receptor has recently been found to be phosphorylated on tyrosine. To assess the possible connection between tyrosine phosphorylation of the NMDA receptor and signaling pathways in the postsynaptic cell, we have investigated the relationship between tyrosine phosphorylation and the binding of NMDA receptor subunits to the SH2 domains of phospholipase C-gamma (PLC-gamma). A glutathione S-transferase (GST) fusion protein containing both the N- and the C-proximal SH2 domains of PLC-gamma was bound to glutathione-agarose and reacted with synaptic junctional proteins and glycoproteins. Tyrosine-phosphorylated PSD-GP180, which has been identified as the NR2B subunit of the NMDA receptor, bound to the SH2-agarose beads in a phosphorylation-dependent fashion. Immunoblot analysis with antibodies specific for individual NMDA receptor subunits showed that both NR2A and NR2B subunits bound to the SH2-agarose. No binding occurred to GST-agarose lacking an associated SH2 domain, indicating that binding was specific for the SH2 domains. The binding of receptor subunits increased after the incubation of synaptic junctions with ATP and decreased after treatment of synaptic junctions with exogenous protein tyrosine phosphatase. Immunoprecipitation experiments confirmed that NR2A and NR2B were phosphorylated on tyrosine and further that tyrosine phosphorylation of each of the subunits was increased after incubation with ATP. The results demonstrate that NMDA receptor subunits NR2A and NR2B will bind to the SH2 domains of PLC-gamma and that isolated synaptic junctions contain endogenous protein tyrosine kinase(s) that can phosphorylate both NR2A and NR2B receptor subunits, and suggest that interaction of the tyrosine-phosphorylated NMDA receptor with proteins that contain SH2 domains may serve to link it to signaling pathways in the postsynaptic cell.
Gurd
J W
JW
Division of Life Sciences, University of Toronto at Scarborough, West Hill, Ontario, Canada.
Bissoon
N
N
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D017629:Gap Junctions / Q000378:metabolism; D005982:Glutathione Transferase / Q000235:genetics; D008562:Membrane Glycoproteins / Q000378:metabolism; D019000:Phosphotyrosine / Q000378:metabolism*; D016548:Prosencephalon / Q000737:chemistry; D017027:Protein Tyrosine Phosphatases / Q000494:pharmacology; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D015398:Signal Transduction; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism*
D008562:Membrane Glycoproteins; D016194:Receptors, N-Methyl-D-Aspartate; D011993:Recombinant Fusion Proteins; D013438:Sulfhydryl Compounds; C030340:elastin microfibril interface located protein; D019000:Phosphotyrosine; D000255:Adenosine Triphosphate; D005982:Glutathione Transferase; D017027:Protein Tyrosine Phosphatases; D010738:Type C Phospholipases